We found no direct link between IL12A/B with ovarian cancer, although pre-activation with IL-12 in ovarian cancer cell lines is shown to improve the efficacy of natural killer cell immunotherapy [41]. The gene discussed is IL12A; the disease is ovarian carcinoma.